 Downloads provided by UsageCounts
Downloads provided by UsageCounts
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script> Copyright policy )
 Copyright policy )The hepatitis B virus is responsible for most of the chronic liver disease and liver cancer worldwide. As actual therapeutic strategies have had little success in eradicating the virus from hepatocytes, and as lifelong treatment is often required, new drugs targeting the various phases of the hepatitis B virus (HBV) lifecycle are currently under investigation. In this review, we provide an overview of potential future treatments for HBV.
Hepatitis B virus, Life Cycle Stages, direct antiviral agents, therapeutic vaccines, Direct antiviral agents; Gene therapy; HBV; Immunotherapy; Therapeutic vaccines; Animals; Antiviral Agents; Genetic Therapy; Hepatitis B; Hepatitis B Vaccines; Hepatitis B, Chronic; Hepatocytes; Humans; Immunotherapy; Life Cycle Stages; Hepatitis B virus, Review, Genetic Therapy, Hepatitis B, gene therapy, Microbiology, Antiviral Agents, QR1-502, Hepatitis B, Chronic, HBV, Hepatocytes, Animals, Humans, Hepatitis B Vaccines, immunotherapy, Immunotherapy, HBV; direct antiviral agents; gene therapy; immunotherapy; therapeutic vaccines
Hepatitis B virus, Life Cycle Stages, direct antiviral agents, therapeutic vaccines, Direct antiviral agents; Gene therapy; HBV; Immunotherapy; Therapeutic vaccines; Animals; Antiviral Agents; Genetic Therapy; Hepatitis B; Hepatitis B Vaccines; Hepatitis B, Chronic; Hepatocytes; Humans; Immunotherapy; Life Cycle Stages; Hepatitis B virus, Review, Genetic Therapy, Hepatitis B, gene therapy, Microbiology, Antiviral Agents, QR1-502, Hepatitis B, Chronic, HBV, Hepatocytes, Animals, Humans, Hepatitis B Vaccines, immunotherapy, Immunotherapy, HBV; direct antiviral agents; gene therapy; immunotherapy; therapeutic vaccines
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% | 
| views | 107 | |
| downloads | 179 | 

 Views provided by UsageCounts
Views provided by UsageCounts Downloads provided by UsageCounts
Downloads provided by UsageCounts